Protalix BioTherapeutics (PBDA.F) Stock Highlights

0.96 | -6.8%

2024-07-04 04:38:36

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The companys products also treat diseases like Fabry disease and cystic fibrosis.The companys primary sources of revenues include its sales of taliglucerase alfa in Brazil and of drug substance to Pfizer under its Amended Pfizer Agreement.

Statistics

Range Today

0.96 1.02

Volume Today 0

Range 1 Year

0.95 1.86

Volume 1 Year 16.09K

Range 3 Year

0.69 3.1

Volume 3 Year 158.89K

Range 10 Year

0.69 26.6

Volume 10 Year 354.05K

Highlights

Market Capitalization 89.79M (small)

Floating Shares 54.52M

Current Price 0.96

Price To Earnings 16.67

Price To Revenue 0.97

Price To Book 2.7

Earnings Per Share 0.07

Payout Ratio 0%

Performance

Latest -6.8%

1 Month -4.95%

3 Months -15.79%

6 Months -41.46%

1 Year -46.07%

3 Years -35.14%

5 Years -74.36%

10 Years -96.23%

Benchmarks

Market Capitalization

262 / 368

Gross Profits

75 / 278

Total Revenue

109 / 300

Total Rank

237 / 368

Free Cashflow

84 / 352

Performance 5 years

217 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.